2e 2 5d 16
19
1b
2e

Archna Bajaj, MD

88 faculty photo 79
Assistant Professor of Clinical Medicine (Translational Medicine and Human Genetics)
28
7d
Physician, Corporal Michael J. Crescenz Philadelphia VA Medical Center
95
Director, Clinical Trials, Penn Medicine Center for Preventive Cardiology and Lipid Management
11
3 5f
Department: Medicine
4 1 b
1d
46 Contact information
40
3400 Spruce Street
32 Hospital of the University of Pennsylvania
38 9010 Maloney Building
Philadelphia, PA 19104
26
2e Office: 215-662-7197
30
9b 12
4 3 3 1d
18 Publications
23 a
3 2 29 4 b 1f
13 Education:
21 7 BS 23 (Electrical Engineering) c
26 Union College, 2004.
21 7 MS 23 (Electrical Engineering) c
26 Union College, 2005.
21 7 MD c
4b Case Western Reserve University School of Medicine, 2012.
21 9 MSCE c
33 University of Pennsylvania, 2017.
c
3 3 3 3 8d Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
5e

Description of Clinical Expertise

c0 lipids, LDL-cholesterol, triglycerides, lipid disorders, familial hypercholesterolemia, lipoprotein(a), hypertriglyceridemia, familial chylomicronemia syndrome, clinical trials
71

Description of Research Expertise

7a lipids, cholesterol, preventive cardiology, clinical trials, lipoprotein(a), familial hypercholesterolemia
e 29
23

Selected Publications

1f5 Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, Dave L. Dixon, Keith C. Ferdinand, Samuel S. Gidding, Edward A. Gill, Terry A. Jacobson, Erin D. Michos, Maya S. Safarova, Daniel E. Soffer, Pam R. Taub, Michael J. Wilkinson, Don P. Wilson, Christie M. Ballantyne: A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology 18(3): e308-e319, May 2024.

104 Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR: Harnessing RNA Interference for Cholesterol Lowering: The Bench to Bedside Story of Inclisiran. J Am Heart Assoc 13(6): e032031, Mar 19 2024.

fb Daniel J Rader, Archna Bajaj: Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease? JACC 81(18): 1793-1796, May 2023.

127 Archna Bajaj, Marina Cuchel: From supravalvular to valvular aortic stenosis: are statins contributing tot he phenotypic shift in homozygous familial hypercholesterolemia? European Heart Journal 43(34): 3240-3242, Sep 2022.

b8 Bajaj A, Rader DJ.: Antisense oligonucleotides for atherosclerotic disease. Nat Med 26(4): 471-472, April 2020.

d7 Bajaj A, Cuchel M.: Homozygous familial hypercholesterolemia: what treatments are on the horizon? Curr Opin Lipidol 31(3): 119-124, June 2020.

1b9 Bajaj A, Ihegword A, Qiu C, Small AM, Wei WQ, Bastarache L, Feng Q, Kember RL, Risman M, Bloom RD, Birtwell DL, Williams H, Shaffer CM, Chen J, Center RG, Denny JC, Rader DJ, Stein CM, Damrauer SM, Susztak K.: Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. Kidney Int 97(5): 1032-1041, May 2020.

187 Bajaj A, Xie D, Cedillo-Couvert E, Charleston J, Chen J, Deo R, Feldman HI, Go AS, He J, Horwitz E, Kallem R, Rahman M, Weir MR, Anderson AH, Rader DJ; CRIC Study Investigators.: Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD. Am J Kidney Dis 73(6): 827-836, June 2019.

e8 Rader DJ, Bajaj A, Khetarpal SA.: Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk. J Am Coll Cardiol 69(7): 801-804, Feb 2017.

1f8 Bajaj A, Damrauer SM, Anderson AH, Xie D, Budoff MJ, Go AS, He J, Lash JP, Ojo A, Post WS, Rahman M, Reilly MP, Saleheen D, Townsend RR, Chen J, Rader DJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*.: Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort). Arterioscler Thromb Vasc Biol 37(10): 1971-1978, Oct 2017.

2c
7 1d
2c back to top
26 Last updated: 12/24/2025
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 2 18